The DOI matches its Crossref record.
Clinical and Cost Impact of Second-opinion Pathology: Review of Prostate Biopsies Prior to Radical Prostatectomy
Abstract
Despite numerous studies evaluating second-opinion surgical programs, we are unaware of work evaluating the cost effectiveness of a second opinion for pathology prior to surgery. One of six pathologists reviewed the pathology of the outside needle biopsies of 535 consecutive men referred to Johns Hopkins Hospital for radical prostatectomy over a 12-month period (from October 1993 until October 1994) before the men underwent surgery. Of the 535 needle biopsies initially diagnosed on the outside as adenocarcinoma of the prostate, seven (1.3%) were reclassified as benign upon pathology review at Johns Hopkins Hospital. The most common lesion misinterpreted as adenocarcinoma was adenosis or less pronounced examples of adenosis consisting of foci of crowded glands (five cases). Foci of atrophy in the remaining two cases were misdiagnosed as adenocarcinoma of the prostate. Upon subsequent clinical work up, six of seven men were considered not to have adenocarcinoma, and their surgery was cancelled. The cost for reviewing all 535 preoperative needle biopsies was $44,883, which included the cost of immunohistochemical studies for high-molecular-weight cytokeratin and repeat biopsies and ultrasounds in men whose diagnoses were reversed. The total cost of the radical prostatectomies had the six men undergone surgery was estimated at $85,686, including hospitalization, anesthesia, radical prostatectomy pathology, and surgery. This cost savings did not include other costs resulting from lost wages, morbidity, or potential litigation. Second-opinion pathological evaluation of prostate biopsy before radical prostatectomy is cost effective and has a major impact on clinical treatment for a subset of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Al-Sukhni, E., Milot, L., Fruitman, M., Beyene, J., Victor, J. C., Schmocker, S., Brown, G., McLeod, R., & Kennedy, E. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2210-5 · Cited by 576
Pathological and molecular aspects of prostate cancer
DeMarzo, A. M., Nelson, W. G., Isaacs, W. B., & Epstein, J. I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12779-1 · Cited by 472
Self-citationMandatory second opinion surgical pathology at a large referral hospital
Kronz, J. D., Westra, W. H., & Epstein, J. I. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991201)86:11<2426::aid-cncr34>3.0.co;2-3 · Cited by 283
Self-citationDoyle, S., Feldman, M., Tomaszewski, J., & Madabhushi, A. (2012) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2010.2053540 · Cited by 253
Nakhleh, R. E., Nosé, V., Colasacco, C., Fatheree, L. A., Lillemoe, T. J., McCrory, D. C., Meier, F. A., Otis, C. N., Owens, S. R., Raab, S. S., et al. (2016) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2014-0511-sa · Cited by 94
Metadata
- Authors
- Epstein, J. I., Walsh, P. C., & Sanfilippo, F.
- Venue
- The American Journal of Surgical Pathology
- Published
- 1996-07
- Volume
- 20
- Issue
- 7
- Pages
- 851-857
- ISSN
- 0147-5185 (ISSN-L)
- OpenAlex
- W1967307149
- Cited by
- 168
- References
- 0
- FWCI
- 3.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical and Cost Impact of Second-opinion Pathology: Review of Prostate Biopsies Prior to Radical Prostatectomy. https://app.cochat.ai/papers/10.1097/00000478-199607000-00008
- The paper
- Epstein, J. I., Walsh, P. C., & Sanfilippo, F. (1996). Clinical and Cost Impact of Second-opinion Pathology: Review of Prostate Biopsies Prior to Radical Prostatectomy. The American Journal of Surgical Pathology. https://doi.org/10.1097/00000478-199607000-00008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.